Published in Am Fam Physician on April 15, 2005
Recommendations to improve preconception health and health care--United States. A report of the CDC/ATSDR Preconception Care Work Group and the Select Panel on Preconception Care. MMWR Recomm Rep (2006) 6.56
New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol (2007) 4.01
Prevalence of parent-reported diagnosis of autism spectrum disorder among children in the US, 2007. Pediatrics (2009) 3.24
The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer. Genet Med (2010) 2.81
Strategies for implementing screening for critical congenital heart disease. Pediatrics (2011) 2.72
Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs. MMWR Recomm Rep (2004) 2.25
Quantifying the health benefits of genetic tests: the importance of a population perspective. Genet Med (2006) 2.11
Preconception care for improving perinatal outcomes: the time to act. Matern Child Health J (2006) 1.93
Estimation of the contribution of non-assisted reproductive technology ovulation stimulation fertility treatments to US singleton and multiple births. Am J Epidemiol (2009) 1.83
From public health emergency to public health service: the implications of evolving criteria for newborn screening panels. Pediatrics (2006) 1.77
Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP. Pediatrics (2009) 1.77
Trends in pediatric sickle cell disease-related mortality in the United States, 1983-2002. J Pediatr (2008) 1.73
Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the American Heart Association and American Academy of Pediatrics. Circulation (2009) 1.72
Distribution, variability, and predictors of urinary concentrations of phenols and parabens among pregnant women in Puerto Rico. Environ Sci Technol (2013) 1.71
Health care expenditures for infants and young children with Down syndrome in a privately insured population. J Pediatr (2008) 1.70
Health care use and health and functional impact of developmental disabilities among US children, 1997-2005. Arch Pediatr Adolesc Med (2009) 1.62
Emergency department visits made by patients with sickle cell disease: a descriptive study, 1999-2007. Am J Prev Med (2010) 1.62
Challenges of translating genetic tests into clinical and public health practice. Nat Rev Genet (2009) 1.62
Health care utilization and expenditures for privately and publicly insured children with sickle cell disease in the United States. Pediatr Blood Cancer (2009) 1.54
Trends in in-hospital deaths among hospitalizations with pulmonary embolism. Arch Intern Med (2012) 1.53
Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders. MMWR Recomm Rep (2004) 1.52
Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research priorities. Med Decis Making (2010) 1.45
Professional Fee Ratios for US Hospital Discharge Data. Med Care (2015) 1.42
Pregnancy outcomes following systemic prenatal acyclovir exposure: Conclusions from the international acyclovir pregnancy registry, 1984-1999. Birth Defects Res A Clin Mol Teratol (2004) 1.35
Recognition and prevention of fetal alcohol syndrome. Obstet Gynecol (2005) 1.35
Health care expenditures of children and adults with spina bifida in a privately insured U.S. population. Birth Defects Res A Clin Mol Teratol (2007) 1.32
Concurrent medical conditions and health care use and needs among children with learning and behavioral developmental disabilities, National Health Interview Survey, 2006-2010. Res Dev Disabil (2011) 1.30
Cost-effectiveness of routine screening for critical congenital heart disease in US newborns. Pediatrics (2013) 1.28
Issues related to the diagnosis and treatment of autism spectrum disorders. Ment Retard Dev Disabil Res Rev (2007) 1.26
Patterns and average volume of alcohol use among women of childbearing age. Matern Child Health J (2007) 1.23
Measures of follow-up in early hearing detection and intervention programs: a need for standardization. Am J Audiol (2008) 1.20
Children with orofacial clefts: health-care use and costs among a privately insured population. Public Health Rep (2009) 1.16
Urinary phthalate metabolite concentrations among pregnant women in Northern Puerto Rico: distribution, temporal variability, and predictors. Environ Int (2013) 1.16
Sickle cell disease-related pediatric medical expenditures in the U.S. Am J Prev Med (2010) 1.16
Parent-reported prevalence of autism spectrum disorders in US-born children: an assessment of changes within birth cohorts from the 2003 to the 2007 National Survey of Children's Health. Matern Child Health J (2012) 1.16
Hospitalizations, costs, and mortality among infants with critical congenital heart disease: how important is timely detection? Birth Defects Res A Clin Mol Teratol (2013) 1.15
Attention-deficit/hyperactivity disorder symptoms and child maltreatment: a population-based study. J Pediatr (2008) 1.14
Autism spectrum disorders and health care expenditures: the effects of co-occurring conditions. J Dev Behav Pediatr (2012) 1.14
The impact of transient hypothyroidism on the increasing rate of congenital hypothyroidism in the United States. Pediatrics (2010) 1.14
Urinary phthalate metabolite associations with biomarkers of inflammation and oxidative stress across pregnancy in Puerto Rico. Environ Sci Technol (2014) 1.13
Medical expenditures for children with an autism spectrum disorder in a privately insured population. J Autism Dev Disord (2007) 1.10
Health state preference scores of children with spina bifida and their caregivers. Qual Life Res (2005) 1.08
Hospital use and associated costs of children aged zero-to-two years with craniofacial malformations in Massachusetts. Birth Defects Res A Clin Mol Teratol (2009) 1.04
Health care utilization and expenditures for children and young adults with muscular dystrophy in a privately insured population. J Child Neurol (2008) 1.04
Healthcare expenditures for privately insured people with cystic fibrosis. Pediatr Pulmonol (2009) 1.01
Attention-deficit/hyperactivity disorder, conduct disorder, and young adult intimate partner violence. Arch Gen Psychiatry (2010) 1.01
Birth weight and health and developmental outcomes in US children, 1997-2005. Matern Child Health J (2011) 1.01
Factors associated with late detection of critical congenital heart disease in newborns. Pediatrics (2013) 1.01
Cost savings from universal newborn hearing screening. Pediatrics (2006) 0.99
Prevalence of congenital hypothyroidism--current trends and future directions: workshop summary. Pediatrics (2010) 0.98
Discontinuation of thyroid hormone treatment among children in the United States with congenital hypothyroidism: findings from health insurance claims data. BMC Pediatr (2010) 0.98
Characteristics of users of intrauterine devices and other reversible contraceptive methods in the United States. Fertil Steril (2011) 0.98
Determining the effect of newborn hearing screening legislation: an analysis of state hearing screening rates. Public Health Rep (2007) 0.97
Health care expenditures associated with venous thromboembolism among children. Thromb Res (2011) 0.96
Prevalence and impact of unhealthy weight in a national sample of US adolescents with autism and other learning and behavioral disabilities. Matern Child Health J (2014) 0.96
The Jamaican historical experience of the impact of educational interventions on sickle cell disease child mortality. Am J Prev Med (2012) 0.95
The economic impact of an urban asthma management program. Am J Manag Care (2009) 0.95
Cost-effectiveness of a folic acid fortification program in Chile. Health Policy (2007) 0.95
Health state preference scores for children with permanent childhood hearing loss: a comparative analysis of the QWB and HUI3. Qual Life Res (2008) 0.93
Prevalence and selected characteristics of childhood vision impairment. Dev Med Child Neurol (2002) 0.92
Predicted contribution of folic acid fortification of corn masa flour to the usual folic acid intake for the US population: National Health and Nutrition Examination Survey 2001-2004. Am J Clin Nutr (2008) 0.92
Labor market productivity costs for caregivers of children with spina bifida: a population-based analysis. Med Decis Making (2008) 0.91
Points to consider in assessing and appraising predictive genetic tests. J Community Genet (2010) 0.91
Hydroxyurea is associated with lower costs of care of young children with sickle cell anemia. Pediatrics (2013) 0.90
A framework for key considerations regarding point-of-care screening of newborns. Genet Med (2012) 0.90
Global regional and national causes of child mortality. Lancet (2012) 0.89
Health utility elicitation: is there still a role for direct methods? Pharmacoeconomics (2012) 0.89
A national profile of health care and family impacts of children with muscular dystrophy and special health care needs in the United States. J Child Neurol (2011) 0.89
Urinary phthalate metabolites in relation to maternal serum thyroid and sex hormone levels during pregnancy: a longitudinal analysis. Reprod Biol Endocrinol (2015) 0.88
Parenting aggravation and autism spectrum disorders: 2007 National Survey of Children's Health. Disabil Health J (2010) 0.88
Trends in venous thromboembolism-related hospitalizations, 1994-2009. Pediatrics (2012) 0.87
Revival of the intrauterine device: increased insertions among US women with employer-sponsored insurance, 2002-2008. Contraception (2011) 0.87
Disability among individuals with sickle cell disease: literature review from a public health perspective. Am J Prev Med (2011) 0.87
Association between parental nativity and autism spectrum disorder among US-born non-Hispanic white and Hispanic children, 2007 National Survey of Children's Health. Disabil Health J (2011) 0.87
Hospitalization for urinary tract infections and the quality of preventive health care received by people with spina bifida. Disabil Health J (2009) 0.86
The role of health technology assessment in coverage decisions on newborn screening. Int J Technol Assess Health Care (2011) 0.85
Medical expenditures of children in the United States with fetal alcohol syndrome. Neurotoxicol Teratol (2010) 0.85
A multiple source methodology for the surveillance of fetal alcohol syndrome--The Fetal Alcohol Syndrome Surveillance Network (FASSNet). Teratology (2002) 0.85
Variation in immunoreactive trypsinogen concentrations among Michigan newborns and implications for cystic fibrosis newborn screening. Pediatr Pulmonol (2010) 0.84
Health care expenditures among children with and those without spina bifida enrolled in Medicaid in North Carolina. Birth Defects Res A Clin Mol Teratol (2011) 0.84
Sickle cell disease incidence among newborns in New York State by maternal race/ethnicity and nativity. Genet Med (2012) 0.84
Medical expenditures attributable to cerebral palsy and intellectual disability among Medicaid-enrolled children. Res Dev Disabil (2012) 0.84
Ethical implications and practical considerations of ethnically targeted screening for genetic disorders: the case of hemoglobinopathy screening. Ethn Health (2011) 0.84
Developing public health surveillance for deep vein thrombosis and pulmonary embolism. Am J Prev Med (2011) 0.84
Measuring health and well-being effects in family caregivers of children with craniofacial malformations. Qual Life Res (2011) 0.83
Age at Autism Spectrum Disorder (ASD) Diagnosis by Race, Ethnicity, and Primary Household Language Among Children with Special Health Care Needs, United States, 2009-2010. Matern Child Health J (2015) 0.83
Decision analysis, economic evaluation, and newborn screening: challenges and opportunities. Genet Med (2012) 0.82
A practical clinical approach to diagnosis of fetal alcohol spectrum disorders: clarification of the 1996 Institute of Medicine criteria. Pediatrics (2005) 0.82
A population-based assessment of the health, functional status, and consequent family impact among children with Down syndrome. Disabil Health J (2010) 0.82
CDC Grand Rounds: preventing hospital-associated venous thromboembolism. MMWR Morb Mortal Wkly Rep (2014) 0.81
Cost-effectiveness of Increasing Access to Contraception during the Zika Virus Outbreak, Puerto Rico, 2016. Emerg Infect Dis (2017) 0.81
Health policy for sickle cell disease in Africa: experience from Tanzania on interventions to reduce under-five mortality. Trop Med Int Health (2014) 0.81
Vital Signs: National and State-Specific Patterns of Attention Deficit/Hyperactivity Disorder Treatment Among Insured Children Aged 2-5 Years - United States, 2008-2014. MMWR Morb Mortal Wkly Rep (2016) 0.80
Conclusions and future directions for periodic reporting on the use of selected clinical preventive services to improve the health of infants, children, and adolescents--United States. MMWR Surveill Summ (2014) 0.80
Insurance coverage of medical foods for treatment of inherited metabolic disorders. Genet Med (2013) 0.80
Birth defects and disabilities: a public health issue for the 21st century. Am J Public Health (2005) 0.80
Prevalence of venous thromboembolism among privately insured US adults. Arch Intern Med (2010) 0.79